Brad Schaeffer, former co-owner and CEO of Zachary, La.-based lab company MedComp Sciences, allegedly billed Medicare and Medicaid for testing 15 substances in urine tests regardless of the treatment plan, according to a Nov. 30 news release from the Justice Department.
Mr. Schaeffer allegedly took several actions to perpetuate the fraud, including writing off patients’ copays and paying kickbacks to physicians disguised as laboratory ownership interests.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
